KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Non-cash Items: 2021-2022

Historic Non-cash Items for AbCellera Biologics (ABCL) over the last 2 years, with Dec 2022 value amounting to $113.4 million.

  • AbCellera Biologics' Non-cash Items rose 112960.82% to $113.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $113.4 million, marking a year-over-year increase of 112960.82%. This contributed to the annual value of $113.4 million for FY2022, which is 112960.82% up from last year.
  • According to the latest figures from Q4 2022, AbCellera Biologics' Non-cash Items is $113.4 million, which was up 405.00% from $22.5 million recorded in Q3 2022.
  • AbCellera Biologics' Non-cash Items' 5-year high stood at $113.4 million during Q4 2022, with a 5-year trough of $100,300 in Q4 2021.
  • For the 2-year period, AbCellera Biologics' Non-cash Items averaged around $29.7 million, with its median value being $20.3 million (2022).
  • Data for AbCellera Biologics' Non-cash Items shows a peak YoY increase of 112,960.82% (in 2022) and a maximum YoY decrease of 20.79% (in 2022) over the last 5 years.
  • Quarterly analysis of 2 years shows AbCellera Biologics' Non-cash Items stood at $100,300 in 2021, then skyrocketed by 112,960.82% to $113.4 million in 2022.
  • Its last three reported values are $113.4 million in Q4 2022, $22.5 million for Q3 2022, and $20.7 million during Q2 2022.